+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
New

India Topical Pain Relief Market Report and Forecast 2025-2034

  • PDF Icon

    Report

  • 250 Pages
  • June 2025
  • Region: India
  • Expert Market Research
  • ID: 6101057
The India topical pain relief market was valued at USD 429.71 Million in 2024, driven by the novel topical pain relief formulations in the region. The market is anticipated to grow at a CAGR of 4.60% during the forecast period of 2025-2034, with the values likely to reach USD 673.74 Million by 2034.

India Topical Pain Relief Market Overview

Topical pain relief refers to products applied directly to the skin to alleviate localized pain through ingredients like menthol, capsaicin, or lidocaine. The topical pain relief market in India is growing due to increased prevalence of musculoskeletal disorders, rising awareness of non-invasive treatments, and a growing demand for pain management solutions in both urban and rural areas.

India Topical Pain Relief Market Growth Drivers

New Product Launches are Boosting the Market Growth

The launch of innovative products is a key driver of growth in the topical pain relief market in India. In September 2024, Mankind Pharma launched Nimulid Strong, a product with a unique 2X diclofenac concentration that targets neck pain and provides faster relief. This entry into the market enhances the competitive landscape, addressing unmet pain management needs and contributing to the sector’s continued expansion.

India Topical Pain Relief Market Trends

The market is witnessing several trends and developments to improve the current scenario. Some of the notable trends are as follows:

Novel Topical Pain Relief Formulations to Support the Market Growth

A growing trend in the India topical pain relief market is the development and approval of novel formulations. In October 2024, Lyka received CDSCO approval for its patent-pending Pregabalin Gel 8% w/w, specifically targeting diabetic neuropathic pain. This innovative topical solution offers reduced side effects compared to oral alternatives, providing effective pain relief and likely driving continued market expansion and value.

India Topical Pain Relief Market Segmentation

The market report offers a detailed analysis of the market based on the following segments:

Market Breakup by Drug Class

  • Opioids
  • Hydrocodone
  • Oxycodone
  • Morphine
  • Fentanyl
  • Others
  • Non-opioids
  • Ibuprofen
  • Naproxen
  • Diclofenac
  • Acetaminophen
  • Lidocaine
  • Capsaicin
  • Corticosteroids
  • Prednisone
  • Dexamethasone
  • Others

Market Breakup by Formulation

  • Creams and Ointments
  • Gel
  • Liquid/Oil
  • Patch
  • Sprays
  • Others

Market Breakup by Packaging Types

  • Tubes
  • Containers & Jars
  • Aerosol Containers
  • Dermal Patches
  • Roll On Bottles

Market Breakup by Distribution Channel

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

India Topical Pain Relief Market Share

Segmentation Based on Drug Class, Non-Opioids to Dominate

The market is categorized into opioids and non-opioids by drug class. Non-opioid topical pain relief products are anticipated to dominate due to increasing consumer preference for safer alternatives with fewer side effects. This shift reflects growing concerns over opioid use, positioning non-opioid formulations as the preferred choice in the topical pain relief market.

Creams and Ointments to Lead the India Topical Pain Relief Market

In terms of formulation, creams and ointments are projected to hold the largest market share. Their versatility, ease of application, and effectiveness in providing localized relief make them highly popular. These formulations are widely available, ensuring continued dominance in the market due to their practical benefits and convenience for users.

Tubes Segmentation Based on Packaging Type to Drive Market Growth

By packaging types, the market is segmented into tubes, containers & jars, aerosol containers, dermal patches, and roll-on bottles. Tubes are expected to lead the market due to their user-friendly, hygienic, and efficient design. The ability to control product dispensing, along with their portability, makes tubes the preferred choice for consumers seeking convenience and precision.

Segmentation Based on Distribution Channel to Drive India Topical Pain Relief Market Expansion

The market is segmented into hospital pharmacies, retail pharmacies, online pharmacies, and others based on distribution channels. Retail pharmacies are expected to dominate due to their established presence and accessibility in both urban and rural areas. Although online pharmacies are growing, retail outlets remain the primary distribution point due to convenience and immediate availability.

India Topical Pain Relief Market Analysis by Region

The topical pain relief market in India exhibits regional variations, with the Western and Northern regions leading in demand due to higher urbanization and healthcare awareness. The Southern region shows significant growth, driven by a growing aging population and increasing healthcare infrastructure. the Eastern region witnesses gradual market expansion as awareness and access to pain relief products improve.

Leading Players in the India Topical Pain Relief Market

The key features of the market report comprise patent analysis, grant analysis, funding and investment analysis, and strategic initiatives by the leading players. The major companies in the market are as follows:

Sanofi

Sanofi India Limited, established in 1956 and headquartered in Mumbai, has expanded its consumer healthcare portfolio with the launch of Combiflam Icyhot in India. This topical analgesic, available in gel and spray formats, targets muscle pain and stiffness by offering icy pain relief and hot muscle relaxation. Sanofi’s involvement in the India topical pain relief market strengthens its long-standing presence in pain management, addressing consumer needs for effective, over-the-counter solutions.

Haleon Group

Haleon Group, established in 2022 and headquartered in the United Kingdom, offers a range of pain relief products such as Iodex Ultragel and Crocin. Iodex Ultragel+, known globally as Voltaren, provides effective relief from sprains, strains, joint pain, and back and neck pain. Haleon’s presence in the topical pain relief market highlights its commitment to offering advanced solutions for everyday pain management.

Bayer AG

Bayer AG, founded in 1863 and headquartered in Leverkusen, Germany, is a global leader in healthcare. In the topical pain relief market, the company offers AleveX, a topical pain relief product with menthol and camphor, available in spray, lotion, and roll-on forms. This innovative solution complements Bayer’s renowned Aleve brand, addressing common pain issues like back and neck pain.

Hisamitsu Pharmaceutical Co., Inc

Hisamitsu Pharmaceutical Co., Inc., established in 1937 and headquartered in Japan, is a leading player in the market. The company’s flagship product, Salonpas, is a top-selling OTC topical analgesic patch, recognized as the market leader since 2016. Hisamitsu’s innovation in transdermal drug delivery systems has significantly contributed to the topical pain relief market, offering effective pain management solutions like Salonpas and Mohrus patches.

Other key players in the market include Johnson & Johnson Services Inc., GlaxoSmithKline plc, Pfizer Inc., Reckitt Benckiser Group, Novartis AG, and Sun Pharmaceutical.

Key Questions Answered in the India Topical Pain Relief Market Report

  • What was the India topical pain relief market value in 2024?
  • What is the India topical pain relief market forecast outlook for 2025-2034?
  • What is the market segmentation based on drug class?
  • What is the market breakup based on the formulation?
  • How is the market segmented based on packaging type?
  • How is the market divided based on the distribution channel?
  • What major factors aid the demand for the India topical pain relief market?
  • How has the market performed so far, and how is it anticipated to perform in the coming years?
  • What are the market's major drivers, opportunities, and restraints?
  • What are the major India topical pain relief market trends?
  • Which drug class is expected to dominate the market segment?
  • Which formulation is projected to lead the market segment?
  • Which packaging type is anticipated to drive the market segment?
  • Which distribution channel is likely to dominate the market segment?
  • Who are the key players in the India topical pain relief market?
  • What is the patent landscape of the market?
  • What are the current unmet needs and challenges in the market?
  • How are partnerships, collaborations, mergers, and acquisitions among the key market players shaping the market dynamics?

This product will be delivered within 3-5 business days.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Topical Pain Relief Market Overview - 8 Major Markets
3.1 Topical Pain Relief Market Historical Value (2018-2024)
3.2 Topical Pain Relief Market Forecast Value (2025-2034)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Topical Pain Relief Market: Disease Overview
5.1 Guidelines and Stages
5.2 Pathophysiology
5.3 Screening and Diagnosis
5.4 Treatment Pathway
6 Patient Profile
6.1 Patient Profile Overview
6.2 Patient Psychology and Emotional Impact Factors
6.3 Risk Assessment and Treatment Success Rate
7 Topical Pain Relief Market - Epidemiology Scenario and Forecast - 8 Major Markets
7.1 India Epidemiology Scenario Overview (2018-2034)
7.2 Prevalence, by Country
7.3 Diagnosed Cases, by Country
7.4 Treatment Seeking Rate, by Country
8 Topical Pain Relief Market Landscape - 8 Major Markets
8.1 Topical Pain Relief Market: Developers Landscape
8.1.1 Analysis by Year of Establishment
8.1.2 Analysis by Company Size
8.1.3 Analysis by Region
8.2 Topical Pain Relief Market: Product Landscape
8.2.1 Analysis by Drug Class
8.2.2 Analysis by Formulation
8.2.3 Analysis by Packaging Type
9 Clinical Trials and Pipeline Analysis
9.1 Analysis by Trial Registration Year
9.2 Analysis by Trial Status
9.3 Analysis by Trial Phase
9.4 Analysis by Therapeutic Area
9.5 Analysis by Geography
9.6 Drug Pipeline Analysis
10 Topical Pain Relief Market Challenges and Unmet Needs
10.1 Treatment Pathway Challenges
10.2 Compliance and Drop-Out Analysis
10.3 Awareness and Prevention Gaps
11 Cost of Treatment
12 Topical Pain Relief Market Dynamics
12.1 Market Drivers and Constraints
12.2 SWOT Analysis
12.2.1 Strengths
12.2.2 Weaknesses
12.2.3 Opportunities
12.2.4 Threats
12.3 PESTEL Analysis
12.3.1 Political
12.3.2 Economic
12.3.3 Social
12.3.4 Technological
12.3.5 Legal
12.3.6 Environment
12.4 Porter’s Five Forces Model
12.4.1 Bargaining Power of Suppliers
12.4.2 Bargaining Power of Buyers
12.4.3 Threat of New Entrants
12.4.4 Threat of Substitutes
12.4.5 Degree of Rivalry
12.5 Key Demand Indicators
12.6 Key Price Indicators
12.7 Industry Events, Initiatives, and Trends
12.8 Value Chain Analysis
13 India Topical Pain Relief Market (218-2034)
13.1 India Topical Pain Relief Market (2018-2034) by Drug Class
13.1.1 Market Overview
13.1.2 Opioids
13.1.2.1 Hydrocodone
13.1.2.2 Oxycodone
13.1.2.3 Morphine
13.1.2.4 Fentanyl
13.1.2.5 Others
13.1.3 Non-opioids
13.1.3.1 Ibuprofen
13.1.3.2 Naproxen
13.1.3.3 Diclofenac
13.1.3.4 Acetaminophen
13.1.3.5 Lidocaine
13.1.3.6 Capsaicin
13.1.3.7 Corticosteroids
13.1.3.8 Prednisone
13.1.3.9 Dexamethasone
13.1.3.10 Others
13.2 India Topical Pain Relief Market (2018-2034) by Formulation
13.2.1 Market Overview
13.2.2 Creams and Ointments
13.2.3 Gels
13.2.4 Liquid/Oil
13.2.5 Patch
13.2.6 Sprays
13.2.7 Others
13.3 India Topical Pain Relief Market (2018-2034) by Packaging Type
13.3.1 Market Overview
13.3.2 Tubes
13.3.3 Containers & Jars
13.3.4 Aerosol Containers
13.3.5 Dermal Patches
13.3.6 Roll On Bottles
13.4 India Topical Pain Relief Market (2018-2034) by Distribution Channel
13.4.1 Market Overview
13.4.2 Hospital Pharmacies
13.4.3 Retail Pharmacies
13.4.4 Online Pharmacies
13.4.5 Others
14 Regulatory Framework
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication Year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
16 Grants Analysis
16.1 Analysis by Year
16.2 Analysis by Amount Awarded
16.3 Analysis by Issuing Authority
16.4 Analysis by Grant Application
16.5 Analysis by Funding Institute
16.6 Analysis by NIH Departments
16.7 Analysis by Recipient Organization
17 Funding and Investment Analysis
17.1 Analysis by Funding Instances
17.2 Analysis by Drug Class of Funding
17.3 Analysis by Funding Amount
17.4 Analysis by Leading Players
17.5 Analysis by Leading Investors
17.6 Analysis by Geography
18 Strategic Initiatives
18.1 Analysis by Partnership Instances
18.2 Analysis by Drug Class of Partnership
18.3 Analysis by Leading Players
18.4 Analysis by Geography
19 Supplier Landscape
19.1 Market Share Analysis, By Country (Top 5 Companies)
19.2 Johnson & Johnson Services Inc.
19.2.1 Financial Analysis
19.2.2 Product Portfolio
19.2.3 Demographic Reach and Achievements
19.2.4 Company News and Development
19.2.5 Certifications
19.3 GlaxoSmithKline plc
19.3.1 Financial Analysis
19.3.2 Product Portfolio
19.3.3 Demographic Reach and Achievements
19.3.4 Company News and Development
19.3.5 Certifications
19.4 Pfizer Inc.
19.4.1 Financial Analysis
19.4.2 Product Portfolio
19.4.3 Demographic Reach and Achievements
19.4.4 Company News and Development
19.4.5 Certifications
19.5 Sanofi
19.5.1 Financial Analysis
19.5.2 Product Portfolio
19.5.3 Demographic Reach and Achievements
19.5.4 Company News and Development
19.5.5 Certifications
19.6 Reckitt Benckiser Group
19.6.1 Financial Analysis
19.6.2 Product Portfolio
19.6.3 Demographic Reach and Achievements
19.6.4 Company News and Development
19.6.5 Certifications
19.7 Haleon Group
19.7.1 Financial Analysis
19.7.2 Product Portfolio
19.7.3 Demographic Reach and Achievements
19.7.4 Company News and Development
19.7.5 Certifications
19.8 Bayer AG
19.8.1 Financial Analysis
19.8.2 Product Portfolio
19.8.3 Demographic Reach and Achievements
19.8.4 Company News and Development
19.8.5 Certifications
19.9 Hisamitsu Pharmaceutical Co.,Inc.
19.9.1 Financial Analysis
19.9.2 Product Portfolio
19.9.3 Demographic Reach and Achievements
19.9.4 Company News and Development
19.9.5 Certifications
19.10 Novartis AG
19.10.1 Financial Analysis
19.10.2 Product Portfolio
19.10.3 Demographic Reach and Achievements
19.10.4 Company News and Development
19.10.5 Certifications
19.11 Sun Pharmaceutical
19.11.1 Financial Analysis
19.11.2 Product Portfolio
19.11.3 Demographic Reach and Achievements
19.11.4 Company News and Development
19.11.5 Certifications
20 Topical Pain Relief Market - Distribution Model (Additional Insight)
20.1 Overview
20.2 Potential Distributors
20.3 Key Parameters for Distribution Partner Assessment
21 Key Opinion Leaders (KOL) Insights (Additional Insight)
22 Payment Methods (Additional Insight)
22.1 Government Funded
22.2 Private Insurance
22.3 Out-of-Pocket

Companies Mentioned

  • Sanofi
  • Haleon Group
  • Bayer AG
  • Hisamitsu Pharmaceutical Co., Inc.

Table Information